Trial of Montelukast for Treatment of Acute Bronchiolitis

• Status: Completed
• Trial end date: 2011-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary rationale for this study is to evaluate the effect of once daily montelukast on duration of acute illness in infants with first-time bronchiolitis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical College of Wisconsin
• Treatments: Montelukast

Criteria

Inclusion Criteria:

• Male or female infants aged 3 to 12 months of age

• Diagnosis by emergency physician of bronchiolitis

Exclusion Criteria:

• Any previous episode, as determined by a physician, of wheezing, bronchiolitis or asthma

• Any history of previous bronchodilator use prior to this illness

• Treatment with corticosteroids in the 14 days prior to the current illness

• Immunosuppression

• Immunodeficiency

• Caregiver does not speak English

• Diagnosis by the treating ED physician of croup

• Diagnosis by the treating ED physician of pneumonia

• Caregiver does not have access to a telephone